The former director of the FDA's Center for Biologics Evaluation and Research (CBER), Peter Marks, has joined Eli Lilly as ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the ...

A jury in a Los Angeles, California court has ordered the company to pay an eye-watering $966 million to the family of Mae ...

Sanofi raised its interest in AlphaMedix when it bought a 16% stake in Orano Med, a subsidiary of French nuclear fuel company ...

Earlier this year at the American Society of Clinical Oncology (ASCO) Congress, pharmaphorum spoke with Redwood City, ...

As one of Frontiers Health’s most recognisable faces (and voices), Jessica DaMassa, founder of WTF Health and long-time emcee of the conference, has had a front-row seat to the events evolution over ...

On the outskirts of the LSX conference in Boston last month, pharmaphorum editor-in-chief Jonah Comstock sat down with Eron Kelly, CEO of Concert AI, to discuss the work his Boston-based start-up is ...

While advances in drug development have accelerated dramatically in recent years, pharmaceutical manufacturing processes have ...

Speculation is building that President Donald Trump may delay the introduction of his 100% tariff rate on pharmaceutical imports in order to negotiate more deals with drugmakers on drug pricing. The ...

Last year, Idorsia Pharma claimed FDA approval for Tryvio (aprocitentan) as the first endothelin receptor antagonist for ...

Kronos was bought out earlier this year for a knockdown price of around $35 million by serial biotech acquisition specialist ...

Scotland was held up as proof that new models of adoption, AI-enabled diagnostics, and genomics can transform care at pace.